Dafna Capital Management is an investment advisor that specializes in managing client portfolios of biotechnology companies.
DAFNA Capital Management, LLC, a Los Angeles based SEC registered investment advisor, specializes in managing long/short portfolios of predominantly publicly traded biotechnology and medical device companies. Founded in 1999, for over 17 years we have merged unparalleled expertise, intellectual curiosity, and investment rigor to fund the future of medicine and prudently manage the wealth entrusted with us by our investors
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 18, 2016
Ardelyx
|
Post-IPO Equity | $110M | Biotechnology | — |